Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Heart (British Cardiac Society)
|
November 16, 2002
Beta blockers in older persons with heart failure: tolerability and impact on quality of life
A J Baxter, A Spensley, A Hildreth, et al.
Epidemiology and Psychiatric Sciences
|
October 3, 2015
Gender-related patterns and determinants of recent help-seeking for past-year affective, anxiety and substance use disorders: findings from a national epidemiological survey
M G Harris, A J Baxter, N Reavley, et al.
Epidemiology and Psychiatric Sciences
|
December 16, 2014
Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
F J Charlson, A J Baxter, T Dua, et al.
Psychological Medicine
|
August 11, 2014
The epidemiology and global burden of autism spectrum disorders
A J Baxter, T S Brugha, H E Erskine, et al.
Alimentary Pharmacology & Therapeutics
|
December 1, 1987
The effect of two alpha 2-adrenoreceptor agonists and an antagonist on gastric emptying and mouth to caecum transit time in humans
A J Baxter, C A Edwards, S Holden, et al.
Epidemiology and Psychiatric Sciences
|
April 25, 2014
The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010
A J Baxter, A J Ferrari, H E Erskine, et al.
Epidemiology and Psychiatric Sciences
|
January 21, 2016
The global coverage of prevalence data for mental disorders in children and adolescents
H E Erskine, A J Baxter, G Patton, et al.
Psychological Medicine
|
July 27, 2012
Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature
A J Ferrari, A J Somerville, A J Baxter, et al.
Gut
|
December 1, 1988
Evaluation of applied potential tomography as a new non-invasive gastric secretion test
A J Baxter, Y F Mangnall, E H Loj, et al.
Journal of Medicinal Chemistry
|
January 5, 1996
Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands
L N Jungheim, T A Shepherd, A J Baxter, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Heart (British Cardiac Society)
|
November 16, 2002
Beta blockers in older persons with heart failure: tolerability and impact on quality of life
A J Baxter, A Spensley, A Hildreth, et al.
Epidemiology and Psychiatric Sciences
|
October 3, 2015
Gender-related patterns and determinants of recent help-seeking for past-year affective, anxiety and substance use disorders: findings from a national epidemiological survey
M G Harris, A J Baxter, N Reavley, et al.
Epidemiology and Psychiatric Sciences
|
December 16, 2014
Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
F J Charlson, A J Baxter, T Dua, et al.
Psychological Medicine
|
August 11, 2014
The epidemiology and global burden of autism spectrum disorders
A J Baxter, T S Brugha, H E Erskine, et al.
Alimentary Pharmacology & Therapeutics
|
December 1, 1987
The effect of two alpha 2-adrenoreceptor agonists and an antagonist on gastric emptying and mouth to caecum transit time in humans
A J Baxter, C A Edwards, S Holden, et al.
Epidemiology and Psychiatric Sciences
|
April 25, 2014
The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010
A J Baxter, A J Ferrari, H E Erskine, et al.
Epidemiology and Psychiatric Sciences
|
January 21, 2016
The global coverage of prevalence data for mental disorders in children and adolescents
H E Erskine, A J Baxter, G Patton, et al.
Psychological Medicine
|
July 27, 2012
Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature
A J Ferrari, A J Somerville, A J Baxter, et al.
Gut
|
December 1, 1988
Evaluation of applied potential tomography as a new non-invasive gastric secretion test
A J Baxter, Y F Mangnall, E H Loj, et al.
Journal of Medicinal Chemistry
|
January 5, 1996
Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands
L N Jungheim, T A Shepherd, A J Baxter, et al.
Page
of 3